Nr 546 week 6 Study guides, Class notes & Summaries

Chamberlain NR 546 Week 6 Addiction Medication Table

NR 546 WEEK 7 ADHD Medication Table (Updated). Methylphenidate (D/L) (Concerta, Ritalin) -Dopamine, norepinephrine inhibitor and releaser (DNRIRe), stimulant, FDA approved for ADHD in children and adults (ages vary based on formulations), narcolepsy. Off-label for treatmentresistant depression. Enhancement DA and NE in certain areas of the brain (dorsolateral prefrontal cortex, medial prefrontal cortex). Primary target symptoms: concentration, attention span, motor hyperactivity,...

Chamberlain NR 546 Week 6 DB Case Study- Alcohol Use Disorder

NR 546 Week 6 Addiction Medications Table | Latest 2023/2024. Maintenance treatment of opioid dependence  Induction of treatment for opioid dependence (Bunavail only) Half-life: Buprenorphine: 24–42 hours Naloxone: 2–12 hours Metabolism: CYP 450 3A4 Notable Side Effects:  Headache, constipation, nausea  Oral hypoesthesia, glossodynia  Orthostatic hypotension  Implant specific: insertion site pain, Initial Dosing Considerations:  Patients must be in a m...

NR 546 Week 6 Case Study; Addiction

CASE STUDY 1 HISTORY OF PRESENT ILLNESS: A 27-year-old male was brought to ED by his wife. He has been experiencing chest pain for 1 day starting at 2:00 a.m. He is triaged to the medical emergency department. Amedical history is taken. The client has no history of myocardial infarction (MI) orhypertension. The client is irritable and hypervigilant. He repeatedly asks the nurse if “you know what you are doing” and becomes increasingly guarded as the intern requests more details about his m...

NR 546 Week 7 ADHD Medication Table Latest. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediate-acting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) Indication (include approved ages) Attention deficit hyperactivity disorder (ADHD) in children and adults (approved ages vary base...

NR 546 Week 7 ADHD Medication Table Latest. Drug Name (include if IR, XR, ODT, LA) Indication (include approved ages) Neurotransmitter(s) Affected Target Symptoms Short-acting, intermediate-acting or long-acting. Duration of action, peak (if noted) Notable side effects /Patient education instructions Methylphenidate (D/L) (Concerta, Ritalin) Indication (include approved ages) Attention deficit hyperactivity disorder (ADHD) in children and adults (approved ages vary base...

NR 546 Week 6 Case Study 2023/2024 | 100% Correct Verified NR 546 Week 6 Case Study 2023/2024 | 100% Correct Verified